Directors Eldora L. Ellison, Ph.D., J.C. Rozendaal, and Deborah Sterling, Ph.D. won individual 2021 LMG Life Sciences Americas Awards.

Sterne Kessler is proud to announce that Directors Matthew Bodenstein, Tracy Durkin, Eldora Ellison, and Robert Sterne are ranked in the 2021 "IAM Strategy 300" for leadership in IP strategy and value creation worldwide.

Director Jorge A. Goldstein, Ph.D. has updated his highly regarded book "U.S. Biotechnology Patent Law" with a 2021 edition now available from Thomson Reuters.

Sterne, Kessler, Goldstein & Fox is pleased to announce the firm’s inclusion in Law360’s 2021 Diversity Snapshot rankings. Among the 79 firms in the “101 to 250 attorneys” size category, Sterne Kessler ranked in the top ten for overall diversity and is among the top five for minority representation among equity partners.

Sterne Kessler and 13 directors have been ranked by Managing IP in their annual "IP Stars" guide for excellence in IP litigation and prosecution.

BTI Consulting Group has recognized Sterne Kessler among select midsize law firms across the country whose clients single them out for “punching way above their weight class.” Top legal decision makers, including in-house counsel, praise the named firms for their understanding of the issues, making deep connections, and providing quick opinions, among other strengths.

For the third consecutive year, Chambers USA has given the firm the only "Band 1" ranking among Washington, D.C.'s top intellectual property law firms in the area of patent prosecution. Directors Robert Greene Sterne and Jorge A. Goldstein, Ph.D. continue to be recognized in this definitive professional guide.